Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16331 studies found for:    Studies With Results
Show Display Options
Rank Status Study
21 Terminated
Has Results
Staples Versus Suture for Cesarean Wound Closure
Condition: Wound
Interventions: Device: Surgical staples;   Device: Absorbable Surgical Suture
22 Completed
Has Results
PinPointe FootLaser for the Treatment of Onychomycosis
Conditions: Infected Toenails;   Onychomycosis
Intervention: Device: PinPointe FootLaser
23 Completed
Has Results
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Ixabepilone;   Drug: Cetuximab
24 Completed
Has Results
Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting
Condition: Healthy
Interventions: Drug: Cefdinir for oral suspension 250 mg/5mL;   Drug: OMNICEF® for oral suspension 250 mg/5mL
25 Completed
Has Results
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: Valsartan/amlodipine 80/5 mg;   Drug: Amlodipine 5 mg
26 Terminated
Has Results
Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Tazarotene Cream 0.1%;   Drug: Adapalene
27 Completed
Has Results
Efficacy and Safety Study of Shenwu Capsule
Condition: Mild Cognitive Impairment
Interventions: Drug: Shenwu Capsule;   Drug: Donepezil
28 Terminated
Has Results
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: bortezomib;   Drug: vorinostat
29 Completed
Has Results
Bortezomib With Melphalan and Prednisone for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Melphalan;   Drug: Prednisone
30 Completed
Has Results
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage I Prostate Cancer;   Stage II Prostate Cancer;   Stage III Prostate Cancer
Interventions: Other: placebo;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Drug: lycopene
31 Completed
Has Results
Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing
Condition: Wounds
Interventions: Drug: Xenaderm Vehicle;   Other: Placebo comparator
32 Completed
Has Results
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
Condition: Heart Failure
Interventions: Device: MADIT-CRT ICD;   Device: MADIT-CRT CRT-D
33 Completed
Has Results
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Condition: Kidney Disease
Interventions: Drug: Lanthanum Carbonate;   Other: 900 mg Phosphate Diet;   Drug: LC Placebo;   Other: Ad Libitum Diet
34 Completed
Has Results
Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting
Conditions: Behavior;   Anxiety
Interventions: Drug: Placebo then intranasal oxytocin;   Drug: Intranasal oxytocin then placebo
35 Completed
Has Results
Incidence of Incomplete Postoperative Neuromuscular Recovery From Anesthesia (P07535)(Completed)
Condition: Neuromuscular Blockade
Intervention: Other: Neuromuscular Blocking Agent (NMBA)
36 Completed
Has Results
Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
Conditions: Opioid-Related Disorders;   Opiate Dependence;   Drug Abuse
Intervention: Drug: Buprenorphine/Naloxone
37 Completed
Has Results
Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
Condition: Neoplasms
Interventions: Drug: Axitinib + Paclitaxel + Carboplatin (Cohort 1);   Drug: Axitinib + Paclitaxel + Carboplatin (Cohort 2);   Drug: Axitinib + Paclitaxel + Carboplatin (Cohort 3);   Drug: Axitinib + Paclitaxel (Cohort 4);   Drug: Axitinib + Docetaxel + Carboplatin (Cohort 4a);   Drug: Axitinib + Docetaxel (Cohort 5);   Drug: Axitinib + Capecitabine (Cohort 6);   Drug: Axitinib + Capecitabine (Cohort 7);   Drug: Axitinib + Gemcitabine + Cisplatin (Cohort 8);   Drug: Axitinib + Pemetrexed + Cisplatin (Cohort 9)
38 Completed
Has Results
Post Market Study Using the Xoft Axxent System
Condition: Breast Cancer
Intervention: Radiation: Electronic brachytherapy (Axxent System)
39 Completed
Has Results
Lens Wear Schedules and End-of-Day Comfort
Condition: Myopia
Interventions: Device: Lotrafilcon B;   Device: Senofilcon A
40 Completed
Has Results
Prospective Survey of Menstrual Migraine & Prevention With Eletriptan
Condition: Migraine
Intervention: Drug: eletriptan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years